AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 196 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,832,914 | +5.4% | 216,228 | -34.2% | 0.00% | 0.0% |
| Q1 2024 | $8,383,984 | +147.3% | 328,526 | -12.3% | 0.00% | +200.0% |
| Q4 2023 | $3,390,818 | +0.7% | 374,676 | -29.0% | 0.00% | 0.0% |
| Q3 2023 | $3,366,184 | +83.5% | 527,615 | +219.0% | 0.00% | 0.0% |
| Q2 2023 | $1,834,286 | +162.6% | 165,400 | +263.5% | 0.00% | – |
| Q1 2023 | $698,425 | -84.9% | 45,500 | -78.1% | 0.00% | -100.0% |
| Q4 2022 | $4,616,851 | +136.9% | 208,060 | +74.3% | 0.00% | +100.0% |
| Q3 2022 | $1,949,000 | -50.7% | 119,366 | -56.2% | 0.00% | -50.0% |
| Q2 2022 | $3,956,000 | +50.8% | 272,289 | +91.7% | 0.00% | +100.0% |
| Q1 2022 | $2,623,000 | -25.1% | 142,009 | -3.6% | 0.00% | 0.0% |
| Q4 2021 | $3,502,000 | +1226.5% | 147,316 | +1276.8% | 0.00% | – |
| Q2 2021 | $264,000 | -6.7% | 10,700 | +7.0% | 0.00% | – |
| Q2 2020 | $283,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 926,454 | $25,556,000 | 5.11% |
| EcoR1 Capital, LLC | 2,103,950 | $59,458,000 | 4.39% |
| RTW INVESTMENTS, LP | 3,995,000 | $103,863,000 | 2.92% |
| Cormorant Asset Management, LP | 2,514,547 | $67,804,000 | 2.59% |
| Boxer Capital, LLC | 1,121,327 | $31,689,000 | 1.39% |
| ACUTA CAPITAL PARTNERS, LLC | 117,500 | $3,321,000 | 0.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 877,011 | $24,784,000 | 0.72% |
| Pinz Capital Management, LP | 50,000 | $1,413,000 | 0.65% |
| Matrix Capital Management Company, LP | 1,200,000 | $33,912,000 | 0.53% |
| Perceptive Advisors | 1,235,818 | $31,613,000 | 0.51% |